Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee E Schechter

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry|June 16, 2009
Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonistsRonald C Bernotas, Steven Lenicek, Schuyler Antane, et al.
Journal of Medicinal Chemistry|October 12, 2010
5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonistsKevin G Liu, Albert J Robichaud, Ronald C Bernotas, et al.
Journal of Medicinal Chemistry|July 21, 2006
Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinityNicole T Hatzenbuhler, Deborah A Evrard, Boyd L Harrison, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonistsKevin G Liu, Albert J Robichaud, Alexander A Greenfield, et al.
Journal of Medicinal Chemistry|May 13, 2005
Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of LecozotanWayne E Childers, Magid A Abou-Gharbia, Michael G Kelly, et al.
Neuropharmacology|July 21, 2009
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonistRobert H Ring, Lee E Schechter, Sarah K Leonard, et al.
Journal of Medicinal Chemistry|October 7, 2008
Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2Nicole T Hatzenbuhler, Reinhardt Baudy, Deborah A Evrard, et al.
Journal of Medicinal Chemistry|October 24, 2007
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonistDerek C Cole, Joseph R Stock, William J Lennox, et al.
Journal of Medicinal Chemistry|September 2, 2009
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonistsDahui Zhou, Gary P Stack, Jennifer Lo, et al.
The International Journal of Neuropsychopharmacology|January 6, 2010
Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonismJason M Dwyer, Brian J Platt, Stacey J Sukoff Rizzo, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|June 16, 2009
Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonistsRonald C Bernotas, Steven Lenicek, Schuyler Antane, et al.
Journal of Medicinal Chemistry|October 12, 2010
5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonistsKevin G Liu, Albert J Robichaud, Ronald C Bernotas, et al.
Journal of Medicinal Chemistry|July 21, 2006
Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinityNicole T Hatzenbuhler, Deborah A Evrard, Boyd L Harrison, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonistsKevin G Liu, Albert J Robichaud, Alexander A Greenfield, et al.
Journal of Medicinal Chemistry|May 13, 2005
Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of LecozotanWayne E Childers, Magid A Abou-Gharbia, Michael G Kelly, et al.
Neuropharmacology|July 21, 2009
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonistRobert H Ring, Lee E Schechter, Sarah K Leonard, et al.
Journal of Medicinal Chemistry|October 7, 2008
Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2Nicole T Hatzenbuhler, Reinhardt Baudy, Deborah A Evrard, et al.
Journal of Medicinal Chemistry|October 24, 2007
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonistDerek C Cole, Joseph R Stock, William J Lennox, et al.
Journal of Medicinal Chemistry|September 2, 2009
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonistsDahui Zhou, Gary P Stack, Jennifer Lo, et al.
The International Journal of Neuropsychopharmacology|January 6, 2010
Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonismJason M Dwyer, Brian J Platt, Stacey J Sukoff Rizzo, et al.
Pageof 7